Compare J.B.Chemicals with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs ABBOTT INDIA - Comparison Results

J.B.CHEMICALS     Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS ABBOTT INDIA J.B.CHEMICALS/
ABBOTT INDIA
 
P/E (TTM) x 16.8 44.7 37.6% View Chart
P/BV x 2.3 12.8 18.1% View Chart
Dividend Yield % 0.5 0.5 94.0%  

Financials

 J.B.CHEMICALS   ABBOTT INDIA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
ABBOTT INDIA
Mar-18
J.B.CHEMICALS/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs3636,110 5.9%   
Low Rs2553,996 6.4%   
Sales per share (Unadj.) Rs169.11,552.2 10.9%  
Earnings per share (Unadj.) Rs16.6188.8 8.8%  
Cash flow per share (Unadj.) Rs23.4196.4 11.9%  
Dividends per share (Unadj.) Rs2.0055.00 3.6%  
Dividend yield (eoy) %0.61.1 59.5%  
Book value per share (Unadj.) Rs172.5796.6 21.7%  
Shares outstanding (eoy) m83.5721.25 393.3%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x1.83.3 56.1%   
Avg P/E ratio x18.626.8 69.6%  
P/CF ratio (eoy) x13.225.7 51.3%  
Price / Book Value ratio x1.86.3 28.2%  
Dividend payout %12.029.1 41.4%   
Avg Mkt Cap Rs m25,827107,376 24.1%   
No. of employees `0003.83.3 113.5%   
Total wages/salary Rs m2,5113,937 63.8%   
Avg. sales/employee Rs Th3,747.49,929.3 37.7%   
Avg. wages/employee Rs Th665.71,185.1 56.2%   
Avg. net profit/employee Rs Th367.81,207.7 30.5%   
INCOME DATA
Net Sales Rs m14,13532,985 42.9%  
Other income Rs m3661,170 31.3%   
Total revenues Rs m14,50134,155 42.5%   
Gross profit Rs m2,1785,245 41.5%  
Depreciation Rs m570162 351.9%   
Interest Rs m3538 91.4%   
Profit before tax Rs m1,9406,215 31.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5522,203 25.1%   
Profit after tax Rs m1,3874,012 34.6%  
Gross profit margin %15.415.9 96.9%  
Effective tax rate %28.535.4 80.3%   
Net profit margin %9.812.2 80.7%  
BALANCE SHEET DATA
Current assets Rs m10,47022,655 46.2%   
Current liabilities Rs m2,7496,681 41.1%   
Net working cap to sales %54.648.4 112.8%  
Current ratio x3.83.4 112.3%  
Inventory Days Days5565 85.2%  
Debtors Days Days7829 266.4%  
Net fixed assets Rs m5,811835 695.6%   
Share capital Rs m167213 78.6%   
"Free" reserves Rs m14,24816,715 85.2%   
Net worth Rs m14,41616,928 85.2%   
Long term debt Rs m00-   
Total assets Rs m17,64924,162 73.0%  
Interest coverage x56.6163.7 34.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.81.4 58.7%   
Return on assets %8.116.8 48.1%  
Return on equity %9.623.7 40.6%  
Return on capital %13.736.9 37.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m6,164369 1,672.5%   
Fx outflow Rs m1,3343,807 35.1%   
Net fx Rs m4,829-3,438 -140.5%   
CASH FLOW
From Operations Rs m1,2311,527 80.6%  
From Investments Rs m-208-2,148 9.7%  
From Financial Activity Rs m-595-1,024 58.1%  
Net Cashflow Rs m427-1,646 -26.0%  

Share Holding

Indian Promoters % 55.4 0.0 -  
Foreign collaborators % 0.3 75.0 0.4%  
Indian inst/Mut Fund % 3.4 7.9 42.9%  
FIIs % 3.9 0.1 3,900.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 17.1 216.4%  
Shareholders   30,437 18,270 166.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   JUBILANT LIFE SCIENCES  DR. DATSONS LABS  ELDER PHARMA  NOVARTIS  PANACEA BIOTECH  

Compare J.B.CHEMICALS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Sep 20, 2019 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - DISHMAN PHARMA COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS